Corex
o
22.06.2022

FDA APPROVES SECOND OVER 50'S COVID BOOSTER

corexvaccines corexnews
FDA APPROVES SECOND OVER 50'S COVID BOOSTER

The FDA has signed off on a second COVID-19 booster for over 50’s.


The second booster shot of both the Pfizer-BioNTech and Moderna Covid-19 vaccines was authorized at the end of March without the opinion of an advisory committee of outside experts.


The FDA have said that they didn’t feel the need for outside opinion based on evidence from an Israeli study which showed that a fourth dose was safe among 600,000 people over the age of 60 who received the Pfizer vaccine. The agency lowered the recommended age to include many who are considered high risk in the 50 and up age group.


The study has also shown positive survival benefits and reduced hospitalisations. The FDA has decided not to wait for an Omicron-specific vaccine, as it’s not yet finished. They also haven’t ruled out the possibility of another shot being authorised later in the year.



Back to the list

Industry insights

Introduction of mandatory labeling

From July 1, 2020, labeling of medicines in Russia will become mandatory for all medical products on the market.

CONTACT US

We’re here to help.
Email us at info@corex-logistics.com or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.